

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.42551760 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 7.12825842 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.96514507 |
| 4 | blood coagulation, intrinsic pathway (GO:0007597) | 4.88165001 |
| 5 | regulation of platelet activation (GO:0010543) | 4.66237628 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59514626 |
| 7 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.55689123 |
| 8 | regulation of platelet aggregation (GO:0090330) | 4.48567570 |
| 9 | neutrophil activation (GO:0042119) | 4.33460088 |
| 10 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.32298810 |
| 11 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.31856090 |
| 12 | lipoxygenase pathway (GO:0019372) | 4.31408103 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.28436024 |
| 14 | adenosine receptor signaling pathway (GO:0001973) | 4.23454402 |
| 15 | platelet aggregation (GO:0070527) | 4.01911586 |
| 16 | negative regulation of norepinephrine secretion (GO:0010700) | 3.95435825 |
| 17 | superoxide anion generation (GO:0042554) | 3.93903065 |
| 18 | * bicarbonate transport (GO:0015701) | 3.91004031 |
| 19 | negative regulation of heart rate (GO:0010459) | 3.88381635 |
| 20 | antibacterial humoral response (GO:0019731) | 3.88090622 |
| 21 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.85067420 |
| 22 | granulocyte activation (GO:0036230) | 3.84567912 |
| 23 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.83827722 |
| 24 | regulation of integrin activation (GO:0033623) | 3.83348380 |
| 25 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.82663376 |
| 26 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.82314319 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.81775322 |
| 28 | ether lipid metabolic process (GO:0046485) | 3.77071750 |
| 29 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.76370055 |
| 30 | phospholipid homeostasis (GO:0055091) | 3.75127056 |
| 31 | low-density lipoprotein particle remodeling (GO:0034374) | 3.72766705 |
| 32 | polyamine biosynthetic process (GO:0006596) | 3.67474619 |
| 33 | sperm capacitation (GO:0048240) | 3.56542883 |
| 34 | negative regulation of platelet activation (GO:0010544) | 3.52255060 |
| 35 | antimicrobial humoral response (GO:0019730) | 3.51288830 |
| 36 | innate immune response in mucosa (GO:0002227) | 3.51081260 |
| 37 | angiogenesis involved in wound healing (GO:0060055) | 3.50758060 |
| 38 | sulfate transmembrane transport (GO:1902358) | 3.45840460 |
| 39 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.45555675 |
| 40 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.41861477 |
| 41 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.41216109 |
| 42 | negative regulation of appetite (GO:0032099) | 3.32715731 |
| 43 | negative regulation of response to food (GO:0032096) | 3.32715731 |
| 44 | fatty acid elongation (GO:0030497) | 3.31099207 |
| 45 | platelet degranulation (GO:0002576) | 3.23270608 |
| 46 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.22789389 |
| 47 | mitochondrial calcium ion transport (GO:0006851) | 3.16512888 |
| 48 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.10830511 |
| 49 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.10119126 |
| 50 | cyclooxygenase pathway (GO:0019371) | 3.09542525 |
| 51 | positive regulation of mast cell activation (GO:0033005) | 3.07929540 |
| 52 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.04331953 |
| 53 | * regulation of intracellular pH (GO:0051453) | 3.03911427 |
| 54 | negative regulation of protein localization to cell surface (GO:2000009) | 3.03686139 |
| 55 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.01981520 |
| 56 | oxygen transport (GO:0015671) | 3.01860773 |
| 57 | positive regulation of blood coagulation (GO:0030194) | 3.01809505 |
| 58 | positive regulation of hemostasis (GO:1900048) | 3.01809505 |
| 59 | beta-amyloid metabolic process (GO:0050435) | 3.00360648 |
| 60 | sulfate transport (GO:0008272) | 3.00203391 |
| 61 | cellular glucuronidation (GO:0052695) | 2.98186152 |
| 62 | homotypic cell-cell adhesion (GO:0034109) | 2.96268836 |
| 63 | bile acid and bile salt transport (GO:0015721) | 2.96043887 |
| 64 | positive regulation of receptor recycling (GO:0001921) | 2.94307193 |
| 65 | regulation of superoxide anion generation (GO:0032928) | 2.93203478 |
| 66 | autophagic vacuole fusion (GO:0000046) | 2.92495902 |
| 67 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.90914720 |
| 68 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.90769176 |
| 69 | platelet formation (GO:0030220) | 2.90754313 |
| 70 | negative regulation of heart contraction (GO:0045822) | 2.90469976 |
| 71 | * regulation of cellular pH (GO:0030641) | 2.90351308 |
| 72 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.89711317 |
| 73 | glycosphingolipid catabolic process (GO:0046479) | 2.85276250 |
| 74 | positive regulation of coagulation (GO:0050820) | 2.85006183 |
| 75 | uronic acid metabolic process (GO:0006063) | 2.84125226 |
| 76 | glucuronate metabolic process (GO:0019585) | 2.84125226 |
| 77 | mucosal immune response (GO:0002385) | 2.82394261 |
| 78 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.82252929 |
| 79 | megakaryocyte development (GO:0035855) | 2.81992407 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 2.77565887 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77565887 |
| 82 | hemoglobin metabolic process (GO:0020027) | 2.77157275 |
| 83 | gas transport (GO:0015669) | 2.76564555 |
| 84 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.75919967 |
| 85 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.75677781 |
| 86 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.71900968 |
| 87 | organ or tissue specific immune response (GO:0002251) | 2.71743913 |
| 88 | regulation of receptor recycling (GO:0001919) | 2.70273567 |
| 89 | * one-carbon metabolic process (GO:0006730) | 2.69423848 |
| 90 | regulation of endothelial cell differentiation (GO:0045601) | 2.68884382 |
| 91 | cellular response to arsenic-containing substance (GO:0071243) | 2.68613758 |
| 92 | amine biosynthetic process (GO:0009309) | 2.68492030 |
| 93 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.66598031 |
| 94 | glycerol ether metabolic process (GO:0006662) | 2.65840209 |
| 95 | hydrogen peroxide catabolic process (GO:0042744) | 2.65329491 |
| 96 | positive regulation of macrophage differentiation (GO:0045651) | 2.64781067 |
| 97 | regulation of lipoprotein metabolic process (GO:0050746) | 2.64495198 |
| 98 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.64178294 |
| 99 | myeloid cell development (GO:0061515) | 2.64075485 |
| 100 | platelet activation (GO:0030168) | 2.63817892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.97262680 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.83895932 |
| 3 | GATA1_19941826_ChIP-Seq_K562_Human | 3.44590941 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.33953746 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.29056398 |
| 6 | GATA2_19941826_ChIP-Seq_K562_Human | 2.85108475 |
| 7 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.84893686 |
| 8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.77824365 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.61870211 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59062579 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44746512 |
| 12 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.43640988 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28987344 |
| 14 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.27149554 |
| 15 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.25900619 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23206179 |
| 17 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.21739695 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.19719693 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.18833172 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06683479 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90829154 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88755345 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80907105 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.78952385 |
| 25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78300851 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.77964091 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77304243 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71095720 |
| 29 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.70085847 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68323131 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66200701 |
| 32 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.61791104 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59988604 |
| 34 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.59598068 |
| 35 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58356152 |
| 36 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.58327239 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57146629 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.53642961 |
| 39 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.53423025 |
| 40 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.53212940 |
| 41 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.53138085 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51585469 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50570727 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49609237 |
| 45 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.48656948 |
| 46 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.44282249 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42322962 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41693089 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41106367 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39257218 |
| 51 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.35956497 |
| 52 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.33943731 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32638710 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32104702 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30687373 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30644378 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26975161 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25582875 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25138439 |
| 60 | NFYA_21822215_ChIP-Seq_K562_Human | 1.22467692 |
| 61 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.21464543 |
| 62 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20968001 |
| 63 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.20123963 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19908582 |
| 65 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18762238 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13564729 |
| 67 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.12953010 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11229344 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10965747 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10750108 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09121295 |
| 72 | NFYB_21822215_ChIP-Seq_K562_Human | 1.08757462 |
| 73 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08273481 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08123116 |
| 75 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.07872736 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06600390 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05501606 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05011066 |
| 79 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04547331 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04358418 |
| 81 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02576060 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02383328 |
| 83 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.02104073 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99711481 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99199698 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98945368 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98097876 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95575646 |
| 89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93654180 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91851439 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90289854 |
| 92 | TBL1_22424771_ChIP-Seq_293T_Human | 0.89874027 |
| 93 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.89445765 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87777821 |
| 95 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86343292 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84736964 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82260210 |
| 98 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80398472 |
| 99 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80107642 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79751288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.94598150 |
| 2 | MP0008004_abnormal_stomach_pH | 4.28363164 |
| 3 | MP0004147_increased_porphyrin_level | 4.23706120 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.91887060 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.08564530 |
| 6 | MP0003724_increased_susceptibility_to | 2.87716759 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.76477791 |
| 8 | MP0005083_abnormal_biliary_tract | 2.64895205 |
| 9 | MP0003303_peritoneal_inflammation | 2.61838672 |
| 10 | MP0005365_abnormal_bile_salt | 2.37111812 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.27235198 |
| 12 | MP0002132_abnormal_respiratory_system | 2.22282390 |
| 13 | MP0000343_altered_response_to | 2.20424635 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.13869130 |
| 15 | MP0001664_abnormal_digestion | 2.05408976 |
| 16 | MP0003866_abnormal_defecation | 2.03580246 |
| 17 | MP0001663_abnormal_digestive_system | 2.00948513 |
| 18 | MP0000490_abnormal_crypts_of | 1.89049902 |
| 19 | MP0000579_abnormal_nail_morphology | 1.87826730 |
| 20 | MP0005636_abnormal_mineral_homeostasis | 1.81712098 |
| 21 | MP0009379_abnormal_foot_pigmentation | 1.71845008 |
| 22 | MP0001765_abnormal_ion_homeostasis | 1.69896004 |
| 23 | MP0004043_abnormal_pH_regulation | 1.64967954 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.61189589 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.61189589 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.58614380 |
| 27 | MP0005381_digestive/alimentary_phenotyp | 1.58307268 |
| 28 | MP0002736_abnormal_nociception_after | 1.54110729 |
| 29 | MP0005187_abnormal_penis_morphology | 1.53174253 |
| 30 | MP0005501_abnormal_skin_physiology | 1.52316596 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.52198309 |
| 32 | MP0008872_abnormal_physiological_respon | 1.50861846 |
| 33 | MP0000230_abnormal_systemic_arterial | 1.48782361 |
| 34 | MP0003638_abnormal_response/metabolism_ | 1.40890643 |
| 35 | MP0006082_CNS_inflammation | 1.34266111 |
| 36 | MP0005410_abnormal_fertilization | 1.33922778 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.33340584 |
| 38 | MP0003186_abnormal_redox_activity | 1.30622186 |
| 39 | MP0001851_eye_inflammation | 1.23602249 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.22945984 |
| 41 | MP0003828_pulmonary_edema | 1.20642090 |
| 42 | MP0000477_abnormal_intestine_morphology | 1.18526178 |
| 43 | MP0002796_impaired_skin_barrier | 1.16031505 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.14383360 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.13685453 |
| 46 | MP0006054_spinal_hemorrhage | 1.13174121 |
| 47 | MP0001849_ear_inflammation | 1.10025607 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.07206580 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.04688777 |
| 50 | MP0001756_abnormal_urination | 1.04593532 |
| 51 | MP0003011_delayed_dark_adaptation | 1.04528365 |
| 52 | MP0003252_abnormal_bile_duct | 1.04496124 |
| 53 | MP0001661_extended_life_span | 1.03569510 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.02001619 |
| 55 | MP0003879_abnormal_hair_cell | 1.00402482 |
| 56 | MP0005165_increased_susceptibility_to | 0.99757126 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.99169832 |
| 58 | MP0003566_abnormal_cell_adhesion | 0.96799403 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 0.95050490 |
| 60 | MP0008260_abnormal_autophagy | 0.95046227 |
| 61 | MP0004215_abnormal_myocardial_fiber | 0.94273297 |
| 62 | MP0009053_abnormal_anal_canal | 0.94123684 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 0.91359712 |
| 64 | MP0009785_altered_susceptibility_to | 0.90814809 |
| 65 | MP0010678_abnormal_skin_adnexa | 0.89824215 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89083393 |
| 67 | MP0001764_abnormal_homeostasis | 0.88962107 |
| 68 | MP0005025_abnormal_response_to | 0.87577814 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 0.87269658 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.85884590 |
| 71 | MP0000249_abnormal_blood_vessel | 0.85417907 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 0.82646277 |
| 73 | MP0001835_abnormal_antigen_presentation | 0.81354672 |
| 74 | MP0004947_skin_inflammation | 0.80898754 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.80694948 |
| 76 | MP0005670_abnormal_white_adipose | 0.80470879 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.80357106 |
| 78 | MP0005666_abnormal_adipose_tissue | 0.80136468 |
| 79 | MP0008874_decreased_physiological_sensi | 0.80096140 |
| 80 | MP0009763_increased_sensitivity_to | 0.77927637 |
| 81 | MP0000383_abnormal_hair_follicle | 0.77693911 |
| 82 | MP0009764_decreased_sensitivity_to | 0.77446087 |
| 83 | MP0002118_abnormal_lipid_homeostasis | 0.76109074 |
| 84 | MP0005409_darkened_coat_color | 0.75669236 |
| 85 | MP0002098_abnormal_vibrissa_morphology | 0.73017303 |
| 86 | MP0002419_abnormal_innate_immunity | 0.72249039 |
| 87 | MP0003195_calcinosis | 0.70320546 |
| 88 | MP0005166_decreased_susceptibility_to | 0.68757675 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.68171256 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.68021966 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.68008717 |
| 92 | MP0005332_abnormal_amino_acid | 0.66944054 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.65495611 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.63708957 |
| 95 | MP0005647_abnormal_sex_gland | 0.63287246 |
| 96 | MP0002398_abnormal_bone_marrow | 0.61686880 |
| 97 | MP0004084_abnormal_cardiac_muscle | 0.61140680 |
| 98 | MP0000598_abnormal_liver_morphology | 0.61070064 |
| 99 | MP0004130_abnormal_muscle_cell | 0.60630901 |
| 100 | MP0002429_abnormal_blood_cell | 0.57487798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 8.14713353 |
| 2 | Prolonged bleeding time (HP:0003010) | 7.60672598 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.28120203 |
| 4 | Abnormal platelet volume (HP:0011876) | 6.70144211 |
| 5 | Menorrhagia (HP:0000132) | 6.32953173 |
| 6 | Purpura (HP:0000979) | 6.26563160 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 5.56010517 |
| 8 | Epistaxis (HP:0000421) | 5.17292185 |
| 9 | Metabolic alkalosis (HP:0200114) | 5.00928384 |
| 10 | Gingival bleeding (HP:0000225) | 4.71994719 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.65894912 |
| 12 | Poikilocytosis (HP:0004447) | 4.64655012 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.99902196 |
| 14 | Abnormal platelet function (HP:0011869) | 3.99493594 |
| 15 | Impaired platelet aggregation (HP:0003540) | 3.99493594 |
| 16 | Acanthocytosis (HP:0001927) | 3.89238996 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 3.82909187 |
| 18 | * Paralysis (HP:0003470) | 3.45427624 |
| 19 | Dyschromatopsia (HP:0007641) | 3.21545656 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12782576 |
| 21 | Hyperaldosteronism (HP:0000859) | 3.07394345 |
| 22 | Decreased circulating renin level (HP:0003351) | 3.05786023 |
| 23 | Hyponatremia (HP:0002902) | 3.05754303 |
| 24 | Polycythemia (HP:0001901) | 3.01723198 |
| 25 | Nausea (HP:0002018) | 3.01015443 |
| 26 | Conjunctival telangiectasia (HP:0000524) | 2.99778839 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.92797215 |
| 28 | Abnormality of chloride homeostasis (HP:0011422) | 2.86768618 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.78683921 |
| 30 | Generalized aminoaciduria (HP:0002909) | 2.77499918 |
| 31 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.76556813 |
| 32 | Alkalosis (HP:0001948) | 2.69415051 |
| 33 | Abnormality of sodium homeostasis (HP:0010931) | 2.68555682 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.62108344 |
| 35 | Ileus (HP:0002595) | 2.53324166 |
| 36 | Irregular epiphyses (HP:0010582) | 2.37465349 |
| 37 | Intrahepatic cholestasis (HP:0001406) | 2.34910358 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.28345539 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.21522117 |
| 40 | Tinnitus (HP:0000360) | 2.18497285 |
| 41 | Spontaneous abortion (HP:0005268) | 2.14652247 |
| 42 | Hypokalemia (HP:0002900) | 2.11775719 |
| 43 | Abnormality of iron homeostasis (HP:0011031) | 2.11594043 |
| 44 | * Hepatosplenomegaly (HP:0001433) | 2.06191158 |
| 45 | Xanthomatosis (HP:0000991) | 2.04966264 |
| 46 | Flattened epiphyses (HP:0003071) | 2.04110656 |
| 47 | Abnormality of magnesium homeostasis (HP:0004921) | 2.03361634 |
| 48 | Joint swelling (HP:0001386) | 2.03206597 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 2.00573100 |
| 50 | Abnormality of lateral ventricle (HP:0030047) | 1.99074892 |
| 51 | Vertebral hypoplasia (HP:0008417) | 1.95793971 |
| 52 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.95793971 |
| 53 | Cholelithiasis (HP:0001081) | 1.89835088 |
| 54 | Short middle phalanx of the 5th finger (HP:0004220) | 1.88755301 |
| 55 | Flat acetabular roof (HP:0003180) | 1.87855286 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 1.87768026 |
| 57 | Hyperalaninemia (HP:0003348) | 1.87768026 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87768026 |
| 59 | Abnormal pupillary function (HP:0007686) | 1.87601328 |
| 60 | Decreased central vision (HP:0007663) | 1.86686817 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 1.86002344 |
| 62 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.85772570 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85739939 |
| 64 | Hyperbilirubinemia (HP:0002904) | 1.85706007 |
| 65 | Acute encephalopathy (HP:0006846) | 1.82541756 |
| 66 | Hypomagnesemia (HP:0002917) | 1.82500282 |
| 67 | Increased circulating renin level (HP:0000848) | 1.81827470 |
| 68 | Abnormal tarsal ossification (HP:0008369) | 1.81503456 |
| 69 | Abnormal spermatogenesis (HP:0008669) | 1.80866255 |
| 70 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78854571 |
| 71 | Bruising susceptibility (HP:0000978) | 1.78655036 |
| 72 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.76660867 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 1.76033246 |
| 74 | Cholecystitis (HP:0001082) | 1.76033246 |
| 75 | Abnormality of macrophages (HP:0004311) | 1.75830277 |
| 76 | Hyperammonemia (HP:0001987) | 1.74934910 |
| 77 | Adrenal overactivity (HP:0002717) | 1.73664434 |
| 78 | Microcytic anemia (HP:0001935) | 1.73559871 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 1.73368671 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 1.69468590 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.68269268 |
| 82 | Abnormality of potassium homeostasis (HP:0011042) | 1.68153050 |
| 83 | Congenital, generalized hypertrichosis (HP:0004540) | 1.67249011 |
| 84 | Male infertility (HP:0003251) | 1.66272487 |
| 85 | Recurrent abscess formation (HP:0002722) | 1.65969259 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 1.65228388 |
| 87 | Increased serum ferritin (HP:0003281) | 1.58861729 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.58087951 |
| 89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.57479017 |
| 90 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.57479017 |
| 91 | Abnormal biliary tract morphology (HP:0012440) | 1.56842407 |
| 92 | Myocardial infarction (HP:0001658) | 1.56796918 |
| 93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.56610837 |
| 94 | Ventricular fibrillation (HP:0001663) | 1.54823383 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 1.54781306 |
| 96 | Loss of speech (HP:0002371) | 1.54744549 |
| 97 | Gonadal dysgenesis (HP:0000133) | 1.54338033 |
| 98 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.54209921 |
| 99 | Abnormal auditory evoked potentials (HP:0006958) | 1.53471225 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.52597201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.70999486 |
| 2 | RIPK4 | 4.25793274 |
| 3 | EIF2AK1 | 4.16391015 |
| 4 | PIK3CA | 3.69787217 |
| 5 | LMTK2 | 3.23082383 |
| 6 | ACVR1B | 2.93897667 |
| 7 | BMX | 2.93524037 |
| 8 | PDK2 | 2.59744780 |
| 9 | MYLK | 2.42670149 |
| 10 | TEC | 2.41030782 |
| 11 | ILK | 1.96167315 |
| 12 | PIK3CG | 1.82909109 |
| 13 | PIM2 | 1.80808894 |
| 14 | NEK1 | 1.70415896 |
| 15 | GRK6 | 1.65531359 |
| 16 | TRIM28 | 1.50432127 |
| 17 | BTK | 1.50198076 |
| 18 | PTK2B | 1.49561096 |
| 19 | PNCK | 1.40521691 |
| 20 | PBK | 1.39389729 |
| 21 | PLK4 | 1.36593251 |
| 22 | TESK2 | 1.29387061 |
| 23 | SYK | 1.27407737 |
| 24 | NME2 | 1.26860417 |
| 25 | BMPR2 | 1.25854476 |
| 26 | TAOK3 | 1.21905724 |
| 27 | FGR | 1.20183621 |
| 28 | STK39 | 1.19738931 |
| 29 | TNIK | 1.19202101 |
| 30 | CSF1R | 1.12792786 |
| 31 | GRK5 | 1.09217259 |
| 32 | ARAF | 1.09156617 |
| 33 | OXSR1 | 1.08312953 |
| 34 | MAP3K12 | 1.05623060 |
| 35 | ZAP70 | 1.03806229 |
| 36 | IKBKB | 1.03400127 |
| 37 | MST1R | 0.97961606 |
| 38 | MAP2K3 | 0.97455599 |
| 39 | BUB1 | 0.97255899 |
| 40 | STK24 | 0.95306101 |
| 41 | BCKDK | 0.94076397 |
| 42 | EPHA2 | 0.93890152 |
| 43 | ABL2 | 0.93149238 |
| 44 | PAK1 | 0.91649137 |
| 45 | FES | 0.91497424 |
| 46 | PLK2 | 0.90264429 |
| 47 | PKN1 | 0.88153568 |
| 48 | STK4 | 0.85703327 |
| 49 | MAPKAPK3 | 0.85112019 |
| 50 | PDPK1 | 0.83833374 |
| 51 | LYN | 0.83289645 |
| 52 | SIK3 | 0.80830025 |
| 53 | EPHB2 | 0.80275826 |
| 54 | ERBB2 | 0.78941925 |
| 55 | STK3 | 0.78105067 |
| 56 | PRKG2 | 0.77125021 |
| 57 | BRSK2 | 0.76849905 |
| 58 | STK16 | 0.76713215 |
| 59 | TAOK1 | 0.76304732 |
| 60 | PDK1 | 0.75360867 |
| 61 | MAP3K5 | 0.71808339 |
| 62 | CAMKK2 | 0.71143853 |
| 63 | DAPK3 | 0.68157704 |
| 64 | MAP3K3 | 0.68112415 |
| 65 | PRKACG | 0.64954221 |
| 66 | MAPK12 | 0.64884674 |
| 67 | BMPR1B | 0.63476942 |
| 68 | TAOK2 | 0.61842983 |
| 69 | ADRBK1 | 0.59671572 |
| 70 | LRRK2 | 0.58778157 |
| 71 | ADRBK2 | 0.52724868 |
| 72 | PIM1 | 0.52568993 |
| 73 | PRKCQ | 0.52326099 |
| 74 | ZAK | 0.49755323 |
| 75 | NUAK1 | 0.48117122 |
| 76 | MINK1 | 0.47055902 |
| 77 | CAMK2G | 0.44041878 |
| 78 | HCK | 0.43697655 |
| 79 | FER | 0.43584588 |
| 80 | JAK2 | 0.42074319 |
| 81 | IRAK1 | 0.41514358 |
| 82 | KDR | 0.40822851 |
| 83 | MATK | 0.40722336 |
| 84 | PRKCD | 0.40505772 |
| 85 | BRAF | 0.40043355 |
| 86 | PRKCA | 0.40037146 |
| 87 | CAMK2D | 0.39378993 |
| 88 | PLK3 | 0.37349956 |
| 89 | DAPK1 | 0.35440896 |
| 90 | MAP3K11 | 0.35379634 |
| 91 | PRKD1 | 0.34956654 |
| 92 | RET | 0.33736920 |
| 93 | MARK3 | 0.33247102 |
| 94 | DMPK | 0.33148008 |
| 95 | MAP2K1 | 0.33012509 |
| 96 | STK10 | 0.32860234 |
| 97 | TNK2 | 0.32695481 |
| 98 | BLK | 0.32585629 |
| 99 | ERBB4 | 0.32025538 |
| 100 | PRKCB | 0.31614147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.08032486 |
| 2 | * Nitrogen metabolism_Homo sapiens_hsa00910 | 4.29358785 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.18072045 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.77213564 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 2.74115978 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.32462041 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29107455 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23745343 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09082490 |
| 10 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.04846152 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.98803169 |
| 12 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.97909372 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.95900843 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.85381737 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.82449905 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81813943 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81061597 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70221664 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.66909243 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66027698 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63151905 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.60411557 |
| 23 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.57775657 |
| 24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.53052763 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51600490 |
| 26 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.49822793 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46227346 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43877748 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42219899 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41256918 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39957442 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38642585 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37571284 |
| 34 | Mineral absorption_Homo sapiens_hsa04978 | 1.32758439 |
| 35 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25585785 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22648393 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21904851 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.17779232 |
| 39 | * Bile secretion_Homo sapiens_hsa04976 | 1.09349378 |
| 40 | * Pancreatic secretion_Homo sapiens_hsa04972 | 1.05813089 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99700551 |
| 42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97721847 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95650023 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91473962 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91277108 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89982749 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87971261 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85844817 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84985392 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84312684 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83212059 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80631279 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.80155810 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79708388 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79188680 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77786440 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77285235 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.74056559 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.73946067 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73457647 |
| 61 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72518809 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68624329 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66578755 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66058440 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65091784 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64157993 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.63796526 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63170339 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62963825 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62603116 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61203197 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59198676 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59103094 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54458407 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.53706146 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52542105 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.52020370 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49843654 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49238934 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47662329 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45079559 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.44904731 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44618171 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.43733213 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43512338 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42907476 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41250598 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40438574 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39864429 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38886655 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37508958 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36374174 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35965023 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34588771 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.33401970 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32419956 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31877935 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.31720032 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.29597368 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28996787 |

